Viewing StudyNCT00456521



Ignite Creation Date: 2024-05-05 @ 5:25 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00456521
Status: COMPLETED
Last Update Posted: 2014-12-17
First Post: 2007-04-03

Brief Title: A Safety and Efficacy Study of Naltrexone SRBupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
Sponsor:
Organization: Orexigen Therapeutics Inc

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 793
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: